With an annual budget of more than 20 M€, CARIM is one of the largest cardiovascular research institutes in Europe, producing more than 500 scientific articles and approximately 40 PhD dissertations per year. In the last ten years, CARIM papers were published in high impact journals such as Cell, JAMA, Nature Medicine, New England Journal of Medicine, Journal of the American College of Cardiology, Circulation, and Lancet Neurology.

CARIM offers a very broad range of facilities covering the entire field of translational cardiovascular research and many internship opportunities, taking advantage of its connection with a large academic hospital. CARIM has an open and dynamic work culture in which talented and ambitious young people work side by side with renowned researchers and medical specialists. CARIM is an active research institute that enables its employees and provides support, such as assistance with applications for research grants and funding, a talent development programme and a Research Council, that reviews project proposals before they are submitted. CARIM provides a dynamic, critical learning environment, which proves to be fertile ground for top achievements in the field of cardiovascular research.

CARIM is one of the six schools of the Faculty of Health, Medicine and Life Sciences (FHML) of Maastricht University and is embedded within the Maastricht University Medical Center+ (Maastricht UMC+). CARIM collaborates closely with the Heart+Vascular Center of Maastricht UMC+.

Fast Facts
• 21.5 M€ annual budget
• annually > 500 publications in Science Citation indexed journals
• 233 researchers, including 98 PhD students
• 67 support staff
• 15 clinical and basic research departments
• Led by Prof. Tilman Hackeng

CARIM employs  150 researchers from
17 departments, about 100 PhD students and
70 technical and support staff members. Together, they are unraveling the mechanisms of cardiovascular disease.


The Maastricht Study
CARIM is one of the initiators of the Maastricht Study; a large, longitudinal population based cohort study focused on type 2 diabetes, and its related co-morbidities. The study will include and track 10,000 individuals living in the Southern part of the Netherlands over a ten-year period. Participants are 40 to 75 years old, and half of them will have type 2 diabetes.
More information >


The Maastricht Heart+Vascular Center (HVC)
Part of the Maastricht UMC+. At HVC, not only are cardiovascular disease treated, but specific advice on lifestyle, weight and diet to prevent cardiovascular disease is given. HVC holds an international top ranking position on Aortic disease, Thrombosis, Arrhythmias and Heart Failure.
More information >